Fever Clinical Trials

A listing of Fever medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 178 clinical trials
Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection

primarily targets the human respiratory system. The most common symptoms are fever, fatigue, and dry cough. During the second week of the disease, part of patients may progress to shortness of breath, then

  • 28 Jan, 2021
  • 10 locations
Blood Concentration in Lorazepam and Treatment in Adult Catatonia

infections (including HIV), typhoid fever, heat stroke, and autoimmune disease]. Benzodiazepines, especially LORAZEPAM, are the most common initial treatment, with a remission rate of approximately

  • 26 Jan, 2021
  • 1 location
Early Life Cohort in Papua Indonesia (ELIPI Study) (ELIPI)

incidence of symptomatic and asymptomatic malaria (P. falciparum and P. vivax) and the associated risk of anaemia. It also provides an opportunity to assess incidence risk of non-malaria febrile illnesses

vivax malaria
Accepts healthy volunteers
  • 12 May, 2022
  • 1 location
An Observational Study of Neurologic Function After COVID-19 Infection

Background COVID-19 is an infection caused by a coronavirus. It can affect different parts of the body. For most people, it causes fevers or trouble breathing

  • 01 Jul, 2022
  • 1 location
Long-Term Respiratory Muscle Strength in Young COVID-19 Patients

therefore presents a variety of symptoms in the acute phase, such as fever, dry cough, fatigue, sore throat, loss of taste or smell, shortness of breath, nasal congestion, chest pain, muscle or joint pain

Accepts healthy volunteers
  • 03 Jun, 2022
  • 1 location
Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management (IMMUNOMARKCOV)

Persons infected with Severe Acute Respiratory Syndrome (SARS) SARS-CoV-2 vary in severity from being asymptomatic to having fever, cough, sore throat, general weakness and fatigue and muscular

  • 05 Apr, 2022
  • 2 locations
Pathogenesis of Physical Induced Urticarial Syndromes

is an autoinflammatory disease, a group of inherited disorders characterized by unprovoked episodes of inflammation. Patients with FCAS often have hives, joint pain, and fever following general

skin punch biopsy
skin biopsy
heat exposure
skin disorder
Accepts healthy volunteers
  • 20 Jun, 2022
  • 1 location
Incidence of Neutropenic Enterocolitis Study in Acute Myeloid Leukemia Patients During Intensive Therapy (DECLAM)

Neutropenia after induction or consolidation therapy for acute myeloid leukemia (AML) patients is associated with a high morbi-mortality rates, especially due to infectious complications. These are managed according to international recommandations (ECIL and IDSA) with antibiotherapy and antifungal strategy. Although the patients suffer of digestive symptoms, intestinale complications are really …

consolidation therapy
  • 27 Feb, 2022
  • 1 location
Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL)

Acute lymphoblastic leukemia (ALL) is the most common cancer of childhood and long-term survival has risen to above 90%, but 1-4% of treated patients die from infections. Early detection and treatment of infection can improve these outcomes by preventing increased severity and death. This study aims to determine whether continuous …

lymphoid leukemia
induction therapy
  • 18 Apr, 2022
  • 1 location
INFLAMmatory BiomarkErs in COVID-19 Participants and Severity of Disease (INFLAME COVID)

Observational Study of the Association of Immunological and Inflammatory Biomarkers in COVID-19 Naïve and Infected Participants and Severity of Disease. Thirty naive and 30 COVID positive participants will have a blood sample taken after informed consent and be assessed for COVID symptoms according to WHO classification. Participants will be followed …

  • 20 Jun, 2022
  • 1 location